| Literature DB >> 16597894 |
A Schnuriger1, S Dominguez, M-A Valantin, R Tubiana, C Duvivier, J Ghosn, A Simon, C Katlama, V Thibault.
Abstract
The performance of a new combined antigen-antibody assay (Monolisa HCV Ag-Ab Ultra; Bio-Rad Laboratories) was evaluated in the context of acute hepatitis C in human immunodeficiency virus-infected patients. The combined assay became positive as early as the first PCR and earlier than a third-generation enzyme-linked immunosorbent assay in 65% of the cases. Reduction of the long period of HCV seronegativity should improve the diagnosis of hepatitis C infection, especially in high-risk populations.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16597894 PMCID: PMC1448659 DOI: 10.1128/JCM.44.4.1561-1563.2006
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948